STOCK TITAN

RAPT Therapeutics, Inc. (RAPT) EPS by Year

RAPT

RAPT Therapeutics, Inc. lost $3.19 per diluted share in fiscal year 2024. The table below carries 7 fiscal years, from 2018 to 2024, and the quarters RAPT Therapeutics, Inc. has filed alongside them.

FY2024 annual
EPS (Diluted) -$3.19
Source SEC Filings (10-K/10-Q) Latest period Q3 FY2025, ended Sep 30, 2025 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

RAPT EPS (Diluted) by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-K
EPS (Diluted)-$3.19-$3.05-18.2%-$2.58-2.0%-$2.53N/AN/AN/A

RAPT EPS (Diluted) by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-QQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-QQ2'2310-QQ1'2310-QQ4'2210-K
EPS (Diluted)-$0.65-$0.65-$0.08-$1.22-$3.79-$5.69-$0.79-3.9%-$0.81-24.6%-$0.82-30.2%-$0.66-6.5%-$0.76-10.1%-$0.65-6.6%

What diluted earnings per share means

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.

More RAPT Therapeutics, Inc. financials

Frequently Asked Questions

What was RAPT Therapeutics, Inc.'s diluted earnings per share in fiscal year 2024?

RAPT Therapeutics, Inc. lost $3.19 per diluted share in fiscal year 2024.

What was RAPT Therapeutics, Inc.'s diluted earnings per share in the most recent quarter?

RAPT Therapeutics, Inc. (RAPT) reported -$0.65 in diluted earnings per share in Q3 2025.

What does diluted earnings per share mean on a financial statement?

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what RAPT Therapeutics, Inc. (RAPT) reported on that line in every period on record.